ANTXR1 and metastatic melanoma: Indeed, a Phase 2 study (NCT019733322) involving vaccination with autologous dendritic cells combined with immunomodulated radiotherapy and/or preleukapheresis interferon-alfa in metastatic melanoma is being conducted to explore TEM8/ANTXR1 upregulation.